Ketotifenum_[INN-Latin]
Category
Ketotifenum_[INN-Latin] Brand names, Ketotifenum_[INN-Latin] Analogs
Ketotifenum_[INN-Latin] Brand Names Mixture
No information avaliable
Ketotifenum_[INN-Latin] Chemical_Formula
C11H12N2S
Ketotifenum_[INN-Latin] RX_link
http://www.rxlist.com/cgi/generic3/levamisole.htm
Ketotifenum_[INN-Latin] fda sheet
Ketotifenum_[INN-Latin] msds (material safety sheet)
Ketotifenum_[INN-Latin] Synthesis Reference
No information avaliable
Ketotifenum_[INN-Latin] Molecular Weight
204.292 g/mol
Ketotifenum_[INN-Latin] Melting Point
264-265 oC
Ketotifenum_[INN-Latin] H2O Solubility
210 mg/mL
Ketotifenum_[INN-Latin] State
Solid
Ketotifenum_[INN-Latin] LogP
2.046
Ketotifenum_[INN-Latin] Dosage Forms
Tablet
Ketotifenum_[INN-Latin] Indication
For adjuvant treatment in combination with fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. Also used to treat malignant melanoma and head/neck cancer.
Ketotifenum_[INN-Latin] Pharmacology
Levamisole is a synthetic imidazothiazole derivative that has been widely used in treatment of worm infestations in both humans and animals. As an anthelmintic, it probably works by targeting the nematode nicotinergic acetylcholine receptor. As an immunomodulator, it appears that Levamisole is an immunostimulant which has been shown to increase NK cells and activated T-cells in patients receiving this adjuvantly along with 5FU for Stage III colon cancer.
Ketotifenum_[INN-Latin] Absorption
Levamisole is rapidly absorbed (2 hours) from the gastrointestinal tract.
Ketotifenum_[INN-Latin] Toxicity
LD50 = 40 mg/kg (Pigs, subcutaneous); LD50 = 180 mg/kg (rat, oral)
Ketotifenum_[INN-Latin] Patient Information
http://www.drugs.com/MTM/letrozole.html
Ketotifenum_[INN-Latin] Organisms Affected
Humans and other mammals